Effects of atorvastatin on leukotriene B4 levels and LDL cholesterol particle size in coronary artery disease patients

Trial Profile

Effects of atorvastatin on leukotriene B4 levels and LDL cholesterol particle size in coronary artery disease patients

Completed
Phase of Trial: Phase II

Latest Information Update: 29 Mar 2012

At a glance

  • Drugs Atorvastatin (Primary)
  • Indications Coronary artery disease
  • Focus Pharmacodynamics
  • Most Recent Events

    • 29 Mar 2012 Results assessing the effects of treatment on low-density lipoprotein cholesterol particle sizes presented at the 16th International Symposium on Atherosclerosis.
    • 29 Mar 2012 Results assessing the effects of treatment on leukotriene B4 levels presented at the 16th International Symposium on Atherosclerosis.
    • 05 Nov 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top